Early diagnosis of invasive pulmonary aspergillosis in hematologic patients: An opportunity to improve the outcome

Haematologica

Volumn 98, Issue 11, 2013, Pages 1657-1660

  Nucci, Marcio ^a   Nouér, Simone A ^a   Cappone, Domenico ^a,b   Anaissie, Elias ^c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; GALACTOMANNAN;

ACUTE GRANULOCYTIC LEUKEMIA; BRONCHIECTASIS; COMPUTER ASSISTED TOMOGRAPHY; CONIDIUM; EARLY DIAGNOSIS; EDITORIAL; FUNGUS CULTURE; HUMAN; LUNG ASPERGILLOSIS; LUNG INFARCTION; LUNG LAVAGE; LYMPHOPROLIFERATIVE DISEASE; MORTALITY; NEUTROPENIA; NEUTROPHIL COUNT; NONHUMAN; OUTCOME ASSESSMENT; PATHOGEN LOAD; SERODIAGNOSIS; TREATMENT RESPONSE;

EARLY DIAGNOSIS; HEMATOLOGIC DISEASES; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; TREATMENT OUTCOME;

EID: 84887005691     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.094359     Document Type: Editorial

References (20)

1. Pagano L, Caira M, Candoni A, Offidani M, Martino B, Specchia G, et al. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica. 2010; 95(4): 644-50.
2. Nucci M, Garnica M, Gloria AB, Lehugeur DS, Dias VC, Palma LC, et al. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. Clin Microbiol Infect. 2013; 19(8): 745-51.
3. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis. 1996; 23(3): 608-15.
4. Maertens J, Buve K, Theunissen K, Meersseman W, Verbeken E, Verhoef G, et al. Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer 2009; 115(2): 355-62.
5. Nucci M, Nouer SA, Grazziutti M, Kumar NS, Barlogie B, Anaissie E. Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies. Clin Infect Dis. 2010; 51(11): 1273-80.
6. Ganzel C, Rowe JM. Prognostic factors in adult acute leukemia. Hematol Oncol Clin North Am. 2011; 25(6): 1163-87.
7. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med. 1998; 339(21): 1506-14.
8. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blade J et al. International staging system for multiple myeloma. J Clin Oncol. 2005; (15)23: 3412-20.
9. Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol. 1997; 15(1): 139-47.
10. Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis. 2007; 44(3): 373-9.
11. Horger M, Hebart H, Einsele H, Lengerke C, Claussen CD, Vonthein R, et al. Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome? Eur J Radiol. 2005; 55(3): 437-44.
12. Hope WW, Petraitis V, Petraitiene R, Aghamolla T, Bacher J, Walsh TJ. The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) beta-d-glucan and consequences of delayed antifungal therapy. Antimicrob Agents Chemother. 2010; 54(11): 4879-86.
13. Kojima R, Tateishi U, Kami M, Murashige N, Nannya Y, Kusumi E, et al. Chest computed tomography of late invasive aspergillosis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005; 11(7): 506-11.
14. Bergeron A, Porcher R, Sulahian A, De Bazelaire C, Chagnon K, Raffoux E, et al. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood. 2012; 119(8): 1831-7.
15. Mircescu MM, Lipuma L, van Rooijen N, Pamer EG, Hohl TM. Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection. J Infect Dis 2009; 200(4): 647-56.
16. Cordonnier C, Botterel F, Ben Anour R, Pautas C, Maury S, Kuentz M, et al. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis. Clin Microbiol Infect. 2009; 15(1): 81-6.
17. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008; 46(12): 1813-21.
18. Girmenia C, Guerrisi P, Frustaci AM, Fama A, Finolezzi E, Perrone S, et al. New category of probable invasive pulmonary aspergillosis in haematological patients. Clin Microbiol Infect. 2012; 18(10): 990-6.
19. Kyo K, Ochi T, Okatani T, Itagaki M, Imanaka R, Katayama Y, et al. Is halo sign the earliest sign of pulmonary invasive aspergillosis (PIA)? Program and Abstracts of the 52th Interscience Conference on Antimicrobial Agents and Chemotherapy 2012; Abstract M-1226.
20. Nouer SA, Nucci M, Kumar NS, Grazziutti M, Barlogie B, Anaissie E. Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: proposal for a new definition. Clin Infect Dis. 2011; 53(7): 671-6.